A carregar...

Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation.

1. Cholecystokinin (CCK) has been shown to diminish opioid analgesia. Here we investigate whether changes in the physiological levels of spinal CCK are responsible for the enhanced potency of spinal morphine in animals following carrageenin inflammation, as compared with normal animals. 2. Single do...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Stanfa, L. C., Dickenson, A. H.
Formato: Artigo
Idioma:Inglês
Publicado em: 1993
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1908163/
https://ncbi.nlm.nih.gov/pubmed/8485635
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!